Last Updated: May 14, 2024
sobi.com has 4 NS records, 1 A records, 0 AAAA records, 2 MX records, and 13 TXT records. Name servers for sobi.com are dns04.ports.net, dns01.dipcon.com, dns02.ports.se, dns03.ports.se. A records for sobi.com are 52.17.142.199. MX records that process @sobi.com email are d223122.a.ess.uk.barracudanetworks.com, d223122.b.ess.uk.barracudanetworks.com. We have observed sobi.com to have 36 subdomains. Technology that may be in use at sobi.com includes globalsign, onetrust, cisco. The domain's primary website is hosted on a Apache web server at 52.17.142.199 in Ireland. The website's description is: "our science | r&d innovative medicines in the pipeline only 5 % of rare diseases have approved medicines. the need for innovative treatments is, therefore, high. a strong pipeline and expanded access are key elements of our commitment to patients. view pipeline investor relations q1 report sobi published its report on 25 april at 08:00 cest. report invitation agm 2024 the annual general meeting will be held on tuesday, 14 may 2024. to related documents report archive media | press releases press releases 8 may, 2024 11:24 sobi has completed sek 3 billion senior bond issue 8 may, 2024 10:15 aspaveli® (pegcetacoplan) approved in europe for use among treatment naïve adult patients with pnh press releases" As of May 14, 2024, sobi.com does not have any threat intelligence reports of concern.
Search DigitalStakeout Footprint to find another asset.
52.17.142.199
No DNS AAAA records
d223122.a.ess.uk.barracudanetworks.com
d223122.b.ess.uk.barracudanetworks.com
dns04.ports.net
dns01.dipcon.com
dns02.ports.se
dns03.ports.se
sobi.com. 300 IN TXT "f77c562c551a48ad801813d01c1ebbb2"
sobi.com. 300 IN TXT "tp60mzdzgsvq6dc6xb7z8gs7y6fjknk6"
sobi.com. 300 IN TXT "_globalsign-domain-verification=vkwZGxsS0qCi6d7CmfseV6o4EltMSW78vYzK0d_fih"
sobi.com. 300 IN TXT "smartsheet-site-validation=rjBfUNPp5MyejeFeU9ZdZ6RXkIt6Daz8"
sobi.com. 300 IN TXT "onetrust-domain-verification=b4efef1336f64cd7ab9a64da4d12110e"
sobi.com. 300 IN TXT "cisco-ci-domain-verification=2ce1f6e40fa549d83716871d0dec5711e062424bb5bf3076e1ca37d1be994aa9"
sobi.com. 300 IN TXT "smartsheet-site-validation=TYdGltjruRgMSmT-dvDQhP94dlf8CV3G"
sobi.com. 300 IN TXT "_globalsign-domain-verification=i1l_tJH18y6hM2QBBpCJceut7pFDJ5Yu5ZPWqcV_6i"
sobi.com. 300 IN TXT "_globalsign-domain-verification=0DY0zEr6NeHa7XPiZaIlRFXHbtNher6S5A_bohOqHs"
sobi.com. 300 IN TXT "_globalsign-domain-verification=HZ2tfoF0beNp1GHb0aHjhpqp6eu21hYelEl-gOhmXG"
sobi.com. 300 IN TXT "v=spf1 mx a:mail.sobi.com ip4:10.106.21.140 ip4:18.168.51.200 ip4:208.185.235.0/24 include:spf.protection.outlook.com include:spf.ess.uk.barracudanetworks.com -all"
sobi.com. 300 IN TXT "lXv7uso3HIOyE4Ir8qa2lqq7w/qJqcmpU+7rJFmyvOE+mGiqFoVrVKyqLB7E3fjInlEbeXvqwQprHmTDuJ3tcQ=="
sobi.com. 300 IN TXT "MS=ms38076706"
sobi.com has 36 subdomains in our inventory.
Apache
Ireland
og:site_name: sobi
og:url: https://www.sobi.com/en/sobi-global
og:title: sobi global
og:description: our science | r&d innovative medicines in the pipeline only 5 % of rare diseases have approved medicines. the need for innovative treatments is, therefore, high. a strong pipeline and expanded access are key elements of our commitment to patients. view pipeline investor relations q1 report sobi published its report on 25 april at 08:00 cest. report invitation agm 2024 the annual general meeting will be held on tuesday, 14 may 2024. to related documents report archive media | press releases press releases 8 may, 2024 11:24 sobi has completed sek 3 billion senior bond issue 8 may, 2024 10:15 aspaveli® (pegcetacoplan) approved in europe for use among treatment naïve adult patients with pnh press releases
og:image: https://www.sobi.com
og:image:url: https://www.sobi.com/themes/sobi/img/logo.svg
{"message_type": "certificate_update", "data": {"leaf_cert": {"not_after": 1706517877, "signature_algorithm": "sha256, rsa", "extensions": {"subjectKeyIdentifier": "B2:3B:BD:A5:99:1B:CC:A3:D9:8A:CE:86:99:D6:7C:6F:00:63:05:B1", "authorityKeyIdentifier": "keyid:0D:98:C0:73:7F:AB:BD:BD:D9:47:4B:49:AD:0A:4A:0C:AC:3E:C7:7C\n", "extendedKeyUsage": "TLS Web server authentication, TLS Web client authentication", "subjectAltName": "DNS:sobi.com, DNS:www.sobi.com", "crlDistributionPoints": "Full Name:\n URI:http://crl.globalsign.com/gsgccr3dvtlsca2020.crl", "keyUsage": "Digital Signature, Key Encipherment", "certificatePolicies": "Policy: 2.23.140.1.2.1\nPolicy: 1.3.6.1.4.1.4146.1.10\n CPS: https://www.globalsign.com/repository/", "ctlSignedCertificateTimestamp": "BIIBaQFnAHUAb1N2rDHwMRnYmQCkURX_dxUcEdkCwQApBo2yCJo32RMAAAGFV-6D_QAABAMARjBEAiAftp-I06PFKOC0bRpj9ymX5VQ7qfGHkhpW3nO4fGBFywIgSl1k-_GKwoclPn2UPINe__ZLXUJl5xP-b_mE__s78YQAdwBVgdTCFpA2AUrqC5tXPFPwwOQ4eHAlCBcvo6odBxPTDAAAAYVX7oQjAAAEAwBIMEYCIQCMjOJPw6_9Z_KJXUri0M3_jkp7DQhxARd8E5X_NFiP8gIhAKOZBVelLo9ljpDOeJJrMooUvfaaDge8PlRlQlQCcLDDAHUAdv-IPwq2-5VRwmHM9Ye6NLSkzbsp3GhCCp_mZ0xaOnQAAAGFV-6EQAAABAMARjBEAiAZ_howLmdhx2xrwJUgap6BIa-InlYVD5rs3euHl41QnQIgS_XeGgewmcB8oatCZx3xIh58GWz2kV3yb4TdEGJBdwU=", "authorityInfoAccess": "OCSP - URI:http://ocsp.globalsign.com/gsgccr3dvtlsca2020\nCA Issuers - URI:http://secure.globalsign.com/cacert/gsgccr3dvtlsca2020.crt\n", "basicConstraints": "CA:FALSE"}, "fingerprint": "5C:0D:B2:B9:AA:8D:C4:5E:F2:30:14:71:2A:C0:E3:31:17:BC:6D:0A", "all_domains": ["sobi.com", "www.sobi.com"], "serial_number": "4003D558A6689EE66F8ECEAA", "subject": {"C": null, "CN": "www.sobi.com", "L": null, "O": null, "ST": null, "emailAddress": null, "OU": null, "aggregated": "/CN=www.sobi.com"}, "not_before": 1672217525, "issuer": {"C": "BE", "CN": "GlobalSign GCC R3 DV TLS CA 2020", "L": null, "O": "GlobalSign nv-sa", "ST": null, "emailAddress": null, "OU": null, "aggregated": "/C=BE/CN=GlobalSign GCC R3 DV TLS CA 2020/O=GlobalSign nv-sa"}}, "cert_link": "https://ct2024.trustasia.com/log2024/ct/v1/get-entries?start=182002&end=182002", "source": {"url": "https://ct2024.trustasia.com/log2024/", "name": "Trust Asia Log2024-2"}, "update_type": "X509LogEntry", "seen": 1680450249.503414, "cert_index": 182002}}